RT Journal Article
T1 Prevalence of Anal High-Risk Human Papilloma Virus Infection and Abnormal Anal Cytology among Women Living with HIV
A1 Munoz-Hernando, Leticia
A1 Oliver-Perez, Reyes
A1 Bravo-Violeta, Victoria
A1 Olloqui, Alejandro
A1 Parte-Izquierdo, Belen
A1 Almansa-Gonzalez, Cristina
A1 Bermejo-Martinez, Rocio
A1 Bolivar-De Miguel, Ana Belen
A1 Diez, Alvaro
A1 Seoane-Ruiz, Jose Miguel
A1 Parrilla-Rubio, Lucia
A1 Tejerizo-Garcia, Alvaro
K1 human papillomavirus
K1 HPV
K1 screening
K1 anal
K1 human immunodeficiency virus
K1 HIV
K1 women
K1 Squamous intraepithelial lesions
K1 Cancer
K1 Terminology
K1 Hpv
AB Background: Women living with human immunodeficiency virus (HIV), WLWHs, are at high risk of developing anal cancer associated with high-risk human papilloma virus infection (HR-HPV). We analyzed the prevalence of anal HR-HPV infection and abnormal anal cytology in a cohort of WLWHs and assessed the risk factors for anal HR-HPV infection. Methods: We present a single-center, observational cross-sectional study. WLWHs who underwent anal cytology and anal human papilloma virus (HPV) testing were selected. High-resolution anoscopy was performed in cases of abnormal anal cytology. All suspicious lesions were biopsied. A univariate and multivariate logistic regression model was used to analyze risk factors for abnormal anal screening. The results are presented as odds ratios (ORs) and 95% confidence intervals (CIs). Results: In total, 400 WLWHs were studied. Of them, 334 met the eligibility criteria and were enrolled in the study. Abnormal anal cytology was detected in 39.5% of patients, and anal HR-HPV in 40.1%, with HPV 16 in 33 (26.6%) of them. Concomitant HR-HPV cervical infection was the only independent risk factor for HR-HPV anal infection (OR 1.67 95% CI, p
PB Mdpi
YR 2022
FD 2022-11-01
LK http://hdl.handle.net/10668/21391
UL http://hdl.handle.net/10668/21391
LA en
DS RISalud
RD Apr 10, 2025